Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance - PubMed (original) (raw)
Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance
Y Fernández et al. Cell Death Differ. 2000 Apr.
Abstract
Metastasis is a highly complex process involving the survival of tumor cells, both in the blood stream and within specific organs. Cell-death and survival are determined by a number of gene products from an expanding family of the Bcl-2 gene, either promoting or preventing apoptosis. Furthermore, the survival of tumor cells may favor the accumulation of additional genetic alterations causing further growth and invasive opportunities which may lead to metastasis. To examine whether the prevention of cell-death influences the metastatic behavior, we transfected a human breast cancer cell line MDA-MB-435 with the Bcl-xL cDNA and then studied metastatic ability of the selected clones in vivo. Our results show that Bcl-xL-clones had a decreased tumor growth latency and an increased metastatic ability. Apoptosis-resistance to cytokines was induced in 435 cells by Bcl-xL-expression with minor modifications in their proliferation rates. These cells also showed diminished adhesion to extracellular matrix proteins and a survival advantage in suspension over 435/Neo cells. Moreover, to determine survival in blood stream and in cells lodged in the lungs, we injected 435/Bcl-xL and 435/Neo cells at 1:3 proportion i.v., and animals were killed at intervals of 15' to 16 h after injection. Tumor cells were recovered from the lungs and Southern-blot analysis revealed the presence of exogenous Bcl-xL cDNA. These results showed that 435/Bcl-xL cells had a survival advantage in circulation over 435/Neo cells. This advantage in vivo was attributable to Bcl-xL expression. We conclude that Bcl-xL expression in breast cancer cells can increase metastatic activity. This advantage could be created by inducing resistance to apoptosis against cytokines, increasing cell survival in circulation, and enhancing anchorage-independent growth.
Similar articles
- Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
España L, Fernández Y, Rubio N, Torregrosa A, Blanco J, Sierra A. España L, et al. Breast Cancer Res Treat. 2004 Sep;87(1):33-44. doi: 10.1023/B:BREA.0000041579.51902.89. Breast Cancer Res Treat. 2004. PMID: 15377849 - Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID, Rosen EM. Fan S, et al. Oncogene. 1998 Jul 16;17(2):131-41. doi: 10.1038/sj.onc.1201943. Oncogene. 1998. PMID: 9674697 - Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole MG, Jasty R, Cooper MJ, Thompson CB, Nuñez G, Castle VP. Dole MG, et al. Cancer Res. 1995 Jun 15;55(12):2576-82. Cancer Res. 1995. PMID: 7780971 - Deregulation of cell death (apoptosis): implications for tumor development.
Pettigrew CA, Cotter TG. Pettigrew CA, et al. Discov Med. 2009 Aug;8(41):61-3. Discov Med. 2009. PMID: 19788869 Review. - [Stimulation of the proliferation of metastatic cancer cells by environmental growth factors and cytokines].
Yamori T, Takeda K. Yamori T, et al. Gan To Kagaku Ryoho. 1999 Jul;26(8):1209-13. Gan To Kagaku Ryoho. 1999. PMID: 10431592 Review. Japanese.
Cited by
- MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.
Hartman ML, Talar B, Gajos-Michniewicz A, Czyz M. Hartman ML, et al. PLoS One. 2015 Jun 2;10(6):e0128796. doi: 10.1371/journal.pone.0128796. eCollection 2015. PLoS One. 2015. PMID: 26035829 Free PMC article. - Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models.
Caldas-Lopes E, Cerchietti L, Ahn JH, Clement CC, Robles AI, Rodina A, Moulick K, Taldone T, Gozman A, Guo Y, Wu N, de Stanchina E, White J, Gross SS, Ma Y, Varticovski L, Melnick A, Chiosis G. Caldas-Lopes E, et al. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8368-73. doi: 10.1073/pnas.0903392106. Epub 2009 May 5. Proc Natl Acad Sci U S A. 2009. PMID: 19416831 Free PMC article. - The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.
Evans SM, Jenkins KW, Chen HI, Jenkins WT, Judy KD, Hwang WT, Lustig RA, Judkins AR, Grady MS, Hahn SM, Koch CJ. Evans SM, et al. Transl Oncol. 2010 Jun 1;3(3):160-9. doi: 10.1593/tlo.09265. Transl Oncol. 2010. PMID: 20563257 Free PMC article. - Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer.
Sarkar S, Mandal M. Sarkar S, et al. Breast Cancer (Auckl). 2009 Aug 17;3:47-60. doi: 10.4137/bcbcr.s2492. Breast Cancer (Auckl). 2009. PMID: 21556249 Free PMC article. - Overexpression of MTA1 promotes invasiveness and metastasis of ovarian cancer cells.
He X, Zhou C, Zheng L, Xiong Z. He X, et al. Ir J Med Sci. 2014 Sep;183(3):433-8. doi: 10.1007/s11845-013-1034-7. Epub 2013 Nov 10. Ir J Med Sci. 2014. PMID: 24214543
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous